Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation

The document highlights the role of metformin in managing Polycystic Ovary Syndrome (PCOS) by improving insulin sensitivity, inhibiting hepatic gluconeogenesis, and affecting lipid metabolism, which together enhance metabolic parameters and restore ovulatory function. It emphasizes that metformin is a key therapy but should be part of a personalized treatment plan that considers individual symptoms and phenotypes. The study also underscores the importance of incorporating non-pharmacological measures and other pharmacological agents into a comprehensive PCOS management strategy.